Navigation Links
PAREXEL International Reports First Quarter Fiscal Year 2013 Results
Date:10/31/2012

the foregoing, the words "believes," "anticipates," "plans," "expects," "intends," "appears," "estimates," "projects," "will," "would," "could," "should,"  "targets," and similar expressions are also intended to identify forward-looking statements.  The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results may differ significantly from the results discussed in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, risks associated with: actual operating performance; actual expense savings and other operating improvements resulting from recent and anticipated restructurings; the loss, modification, or delay of contracts which would, among other things, adversely impact the Company's recognition of revenue included in backlog; the Company's dependence on certain industries and clients; the Company's ability to win new business, manage growth and costs, and attract and retain employees; the Company's ability to complete additional acquisitions and to integrate newly acquired businesses or enter into new lines of business; the impact on the Company's business of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.
Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended June 30, 2012 as filed with the SEC on August 27, 2012, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company speci
'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. PAREXEL International To Present At Goldman Sachs Healthcare Conference And Jefferies Healthcare Conference
2. PAREXEL Chairman and CEO to Deliver Keynote at MassBio CRO/CMO Symposium
3. PAREXEL and ASAN Medical Center Establish Alliance to Accelerate Korea-based Drug Development and Commercialization Programs
4. PAREXEL Appoints Former Senior FDA Official David Elder to Global Team of Strategic Compliance Experts
5. PAREXEL International to Present at J.P. Morgan Healthcare Conference
6. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
7. ABTCP: Internationale Krise beeinflusst den Papier- und Zellstoffmarkt, doch Brasilien investiert weiterhin in Innovationen
8. BioSpain 2012 is Larger in Terms of Internationalisation and the Number of Exhibitors, Meetings and Visitors
9. PROLOR Biotech To Present Data On Its Long-Acting Human Growth Hormone At International NeuroEndocrine Meeting
10. VWR International, LLC Acquires Sovereign Group
11. Ohio State Hosting International Personalized Health Care Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014 A new market ... world is available from Strategic Consulting, Inc., the ... Industrial Microbiology Market Review, Fourth Edition: Global Review ... (IMMR—4) tracks and compares microbiology test volumes, market ... Europe and Asia, and forecasts future volumes and ...
(Date:8/28/2014)... PrimeSource Building Products, Inc., a leading ... to support their communication needs with the ... conferencing platform GlobalMeet powered by SoundConnect. The solution ... SoundConnect delivers award winning “results driven” business class ... be utilizing GlobalMeet powered by SoundConnect ...
(Date:8/28/2014)... 2014 Whitehouse Laboratories is excited to ... with PTI Inspection Systems that will enable ... the art leak testing method development and validation programs ... available. As part of this agreement, Whitehouse Labs has ... Detection Instrument developed and manufactured by PTI. The ...
(Date:8/27/2014)... Green & Grow Inc. (GGI) has ... and secured Otter Capital as a significant new partner. ... of GGI’s Agriplier™ technology, building on recent compelling field ... our first meeting, we have been impressed with Otter ... said Alan Sobba, President and CEO of GGI. “We ...
Breaking Biology Technology:2 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 22 Billion Industrial Microbiology Tests Conducted for Product Quality and Safety Worldwide 3PrimeSource Chooses SoundConnect as Collaboration Provider 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3
... the launch of the FBRM® C35, designed to ... ... ... probe-based FBRM (Focused Beam Reflectance Measurement) technology the ...
... systems in product design and development, manufacture, ... ... Md., Oct. 1 Cylex has announced receipt of,certification ... with the Canadian Medical Devices Conformity Assessment,System (CMDCAS). These ...
... Million Strategic Investment in PharmAthene, ANNAPOLIS, Md., ... a biodefense company developing medical countermeasures,against biological and ... a strategic alliance with Panacea Biotec Ltd., that ... Biotec, through its,subsidiary, Kelisia Holdings Ltd., of $13.1 ...
Cached Biology Technology:Monitor Granule Growth in Process with the FBRM C35 2Cylex(TM) Receives ISO 13485:2003 and 9001:2000 Quality Certifications 2PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 2PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 3PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 4PharmAthene and Panacea Biotec Ltd. Establish Strategic Alliance in Biodefense and Emerging Infectious Diseases 5
(Date:8/29/2014)... . The ... oldest form of communication. Acting as messenger molecules, pheromones ... attraction between males and females. Fish rely on pheromones ... in males and females. Scientists at the Marine Science ... Portugal, and at the Max Planck Institute for Chemical ...
(Date:8/29/2014)... USA - The rise of the Tibetan plateau -- ... -- is important for both its profound effect on ... study published in GSA Bulletin , Katharine Huntington ... isotope thermometry -- using modern and fossil snail shells ... in southwestern Tibet. , Views range widely on ...
(Date:8/28/2014)... new study reports that an expansion of marine protected ... key ecological functions. According to investigators from the ... protecting fish have focused on saving the largest numbers ... that provide key and difficult-to-replace ecological functions. ... performed by fish species that also are food for ...
Breaking Biology News(10 mins):Ready for mating at the right time 2Ready for mating at the right time 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7Study finds marine protected areas inadequate for protecting fish and ocean ecology 2
... top student prize at the SCINEMA Festival of Science Film ... one of several Australian filmmakers whose films garnered awards from ... New Zealand during National Science Week (August 15 23). ... Science Week at Questacon in Canberra this morning. ...
... Cambridge, Mass. August 12, 2009 A multidisciplinary ... received a $10 million National Science Foundation (NSF) Expeditions ... mobile robotic devices. Inspired by the biology of a ... to push advances in miniature robotics and the design ...
... flu vaccine trials, led by the University of Leicester and ... the Leicester Royal Infirmary. Dr Iain Stephenson, a consultant ... at the University, has been carrying out research into swine ... Now he is working with 175 volunteers, aged 18-50, as ...
Cached Biology News:Australian filmmakers are stars of science film awards 2Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices 2Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices 3Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices 4Britain's first swine-flu trials under way 2
Request Info...
Autoclavable, variable volumefitted w./ an anti-drip safety valve; borosilicate glass barrelprotected with transparentpolypropylene sleeve; spring-lock cursor design ensuresfine adjustment for exact ...
Spaced cover glasses to promote effective hybridization...
Disposable tips with floating filter (US Patent 6,702,990) for PDM1.5 OneTouch Plus spotpicker, 10 racks of 96, DNAse and RNAse free...
Biology Products: